| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by financing activities | 84,664 | 3,446 |
| Effects of exchange rates on cash | 745 | 827 |
| Net increase (decrease) in cash and cash equivalents | 96,264 | 55,227 |
| Cash and cash equivalents at beginning of period | 242,077 | - |
| Cash and cash equivalents at end of period | 338,341 | - |
IONIS PHARMACEUTICALS INC (IONS)
IONIS PHARMACEUTICALS INC (IONS)